peptide-information

Peptides are chemically reactive molecules, and the way a sample is stored governs how quickly its sequence loses homogeneity. This overview summarizes what the peptide- and protein-stability literature reports about temperature, freeze–thaw handling, oxidation, light, moisture and container choice for laboratory materials handled under research-use-only conditions.

Why storage determines peptide integrity

A peptide is a defined sequence of amino acids, and the reproducibility of any experiment that uses it depends on that sequence remaining intact and homogeneous. Unlike small, inert molecules, peptides carry reactive side chains and labile backbone bonds that can undergo spontaneous chemical change over time. When a fraction of the material oxidizes, deamidates, isomerizes or aggregates, the sample becomes a mixture of the intended species and its degradation products — a shift that can confound analytical results without any visible change to the vial.

The central principle running through the stability literature is that formulating and storing peptides in a dry, solid form markedly slows chemical degradation relative to solution.¹ Freeze-drying (lyophilization) removes the water that participates in and mobilizes many degradation reactions, which is why most research peptides are shipped as a lyophilized powder. Solid-state formulation is a well-established strategy for maintaining protein and peptide integrity during storage, transport and handling.¹ Even in the solid state, however, reactions continue at a reduced rate, and the physical environment of the dried material — its residual moisture, surface area and the fraction of molecules exposed at the solid–air interface — measurably influences how fast degradation proceeds.²

Storage conditions are therefore best understood not as a single instruction but as a set of levers — temperature, light, air, moisture, mechanical stress and container chemistry — each acting on a specific degradation pathway. The sections below map those levers onto the underlying chemistry.

Temperature: refrigeration, freezing and long-term storage

Temperature is the most influential single variable because the rate of essentially every chemical degradation reaction increases with heat. Studies of asparagine deamidation, for example, report substantially faster rates at 40 °C than at 5 °C, consistent with an Arrhenius temperature dependence.⁸ Lowering the storage temperature is the most general way to slow the full set of pathways at once.

For short handling windows, refrigeration at 2–8 °C is the conventional condition for lyophilized peptides that will be used within days to weeks. Lyophilized single-domain antibody fragments, as one documented example, retained integrity, showed no aggregation and preserved functionality after storage at 2–8 °C for periods extending to 12–18 months in that study.³ Lyophilized material is generally the most forgiving form with respect to short-term temperature excursions.

For longer archival storage — months to years — deeper freezing is the standard laboratory approach, with −20 °C and −80 °C freezers both in common use. The rationale is straightforward: colder storage suppresses reaction rates further and reduces residual molecular mobility in the solid. It is worth emphasizing that freezing slows chemistry rather than stopping it; degradation of freeze-dried material still correlates with formulation physical properties and with the fraction of molecules at the solid–air interface, even at low temperature.² Frost-free (auto-defrost) freezers are typically avoided for archival peptide storage because their defrost cycles impose repeated temperature fluctuations on the contents.

The chemistry of peptide degradation

Understanding storage recommendations is easier once the underlying reactions are named. Peptide degradation partitions into chemical routes, which alter covalent structure, and physical routes, which alter the association state without breaking bonds.

Oxidation

Oxidation targets the electron-rich side chains. Methionine is particularly susceptible to oxidation by reactive oxygen species even under mild conditions, forming methionine sulfoxide, a change that can perturb structure and biological activity in protein therapeutics.⁵ Cysteine (through its thiol) and tryptophan are also prime oxidation targets. Because atmospheric oxygen drives these reactions, minimizing air contact — and, in some workflows, overlaying an inert gas such as nitrogen or argon — is the standard countermeasure for sequences rich in methionine, cysteine or tryptophan.

Deamidation and isomerization

Asparagine and glutamine residues undergo deamidation, in which the side-chain amide converts to a carboxylic acid. For asparagine, the reaction typically proceeds through a cyclic succinimide intermediate that hydrolyzes to a mixture of aspartate and iso-aspartate, and can also racemize.⁷ The classic model-peptide work of Geiger and Clarke showed that the hexapeptide Val–Tyr–Pro–Asn–Gly–Ala deamidated with a half-life of only about 1.4 days at 37 °C and pH 7.4, and that replacing the neighboring glycine with a bulkier residue slowed the reaction 33–50-fold — establishing Asn–Gly as a degradation “hot spot” governed by local sequence.⁷ Deamidation rate is strongly dependent on pH and temperature, and its pH profile can even reverse direction between 40 °C and 5 °C.⁸ In folded proteins, three-dimensional structure can shield susceptible residues: deamidation at a given asparagine accelerated roughly 31-fold upon denaturation in one study, showing that conformation, not just sequence, sets the rate.⁹¹⁰ The resulting iso-aspartate is not a benign endpoint — iso-aspartate formation in peptide fragments has been shown to promote aggregation.¹²

Pyroglutamate and hydrolysis

An N-terminal glutamate or glutamine can cyclize to pyroglutamate during storage; this reaction shows a marked pH dependence and proceeds in both solution and lyophilized solids, so it is not eliminated by drying alone.¹¹ Backbone hydrolysis — cleavage of peptide bonds — requires water and is therefore largely a solution-phase concern, one reason dry storage is favored.

Aggregation

Aggregation is the principal physical route: individual molecules associate into dimers, oligomers and higher-order species. Aggregation can be seeded by chemical damage (iso-aspartate, for instance¹²) and by mechanical and thermal stress, and freezing and thawing are recognized stress points that can drive it.⁴

Freeze–thaw cycles and aliquoting

Freezing is protective for storage but the transitions into and out of the frozen state are themselves a stress. During freezing and thawing, solutes concentrate, pH can shift as buffer components crystallize, and interfaces form — conditions associated with physical instability and aggregate formation. A systematic study of a monoclonal antibody found that freeze–thaw damage in aqueous solution was significant but could be markedly reduced by identifying optimal freeze–thaw conditions, underscoring that the number and manner of cycles matters.⁴

The practical response, standard across laboratories, is aliquoting: dividing a reconstituted stock into single-use portions before freezing so that each experiment thaws a fresh aliquot and the remaining material is never repeatedly cycled. Aliquoting converts a sample that might see dozens of freeze–thaw events into a set of samples that each see one, and it is among the most reliable measures a researcher can take to limit cumulative physical degradation. When a reconstitution diluent such as bacteriostatic water is used to prepare a stock, planning aliquot volumes to match anticipated experimental needs avoids unnecessary repeated withdrawals from a single vial.

Light, air and moisture

Three ambient factors round out the storage picture. Light drives photodegradation: the aromatic residues tryptophan, tyrosine and phenylalanine, together with cysteine/cystine, are the primary sites of photo-oxidation in proteins, and light exposure can alter primary, secondary and tertiary structure.⁶ Storing peptides in the dark, or in amber or foil-wrapped containers, removes this input.

Air supplies the oxygen that drives side-chain oxidation, so keeping containers closed as much as possible and limiting headspace exposure protects oxidation-prone sequences; some workflows reseal the vial under a dry inert gas after each withdrawal.⁵ Moisture is a particular hazard when a cold vial is opened: water condenses on the cold surface of the lyophilizate, introducing the very water that dry storage is meant to exclude and that enables hydrolysis and mobilizes other reactions. Allowing a vial to equilibrate to room temperature before opening is the standard step used to limit condensation-driven moisture uptake.

Storing peptides in solution

Once reconstituted, a peptide re-enters the aqueous environment where degradation is fastest, so solution shelf life is far shorter than that of the lyophilized powder. Water participates directly in hydrolysis, mobilizes deamidation and isomerization, and supports the possibility of microbial contamination. Sequences containing cysteine, methionine, tryptophan, asparagine, glutamine and N-terminal glutamate are especially vulnerable in solution because each maps onto one of the chemical routes above.⁵⁷¹¹

When solution storage is unavoidable, the literature points to a few mitigations. Mildly acidic conditions, around pH 5–6, sit near the reported minimum of the deamidation rate–pH profile for many sequences, whereas neutral-to-basic conditions accelerate it.⁸ Keeping solutions cold slows the same reactions, and dividing the solution into aliquots avoids repeated freeze–thaw of the whole stock. Even researchers who prefer solution convenience commonly freeze aliquots of any inherently unstable sequence when it is not in active use. As a general expectation set by the underlying chemistry, reconstituted peptide is a days-to-weeks material under refrigeration rather than a months-to-years one.

Containers and surface adsorption

The container is an often-overlooked variable, and two distinct issues arise. The first is chemical resistance and physical integrity: storage vials should be clean, structurally sound and chemically compatible with the contents. High-quality glass and chemically resistant plastics such as polypropylene are both used; peptides are frequently shipped in plastic to guard against breakage and can be transferred between vessels as needed.

The second issue is adsorption — peptide molecules binding to the container wall and effectively disappearing from solution. This is a documented, sequence-dependent phenomenon: in proteomic sample preparation, hydrophobic peptides preferentially adsorb onto polypropylene vials, producing non-uniform signal loss, and switching to vials made of more polar polymers such as poly(methyl methacrylate) or polyethylene terephthalate substantially reduced that loss.¹³ A parallel finding for peptide-like cyanotoxins showed that several congeners adsorbed onto polystyrene, polypropylene, high-density polyethylene and polycarbonate containers with recoveries below 70%, while glass and PETG containers preserved concentration.¹⁴ The practical implication is that for dilute solutions of hydrophobic peptides, container material can materially affect how much peptide remains available, and glass or polar-polymer vessels are the more conservative choice.

A practical storage framework

The table below consolidates the general handling patterns that follow from the chemistry above. The stability windows are broad orientation ranges reflecting common laboratory practice, not guarantees for any specific sequence; individual peptides vary widely and a certificate of analysis or empirical stability testing governs any particular material.

Reduced to a checklist, the recurring themes are: keep peptides cold, dark and dry; minimize air and moisture contact; avoid repeated freeze–thaw by aliquoting; store in solution only when necessary and for as short a time as possible; and choose containers with the sequence’s hydrophobicity in mind. Each item traces back to a specific, characterized degradation pathway rather than to convention alone. Common research materials such as BPC-157 and other lyophilized peptides are handled under these same general principles.

All Qovigen peptides are sold for laboratory and research use only (RUO). Not for human or veterinary use, diagnosis, or treatment.